精品国产一区二区桃色

In Memoriam

In memoriam: William Weis

Lydia Smith
March 11, 2024

William “Bill” Weis, former chair of structural biology at Stanford Medicine, died Oct. 13 in Palo Alto, California. He was 64 and had glioblastoma.

William Weis

Weis was born on June 10, 1959, in Queens, New York. In 1981, he received a bachelor’s degree in biochemical sciences from Princeton University. He earned a Ph.D. in biochemistry from Harvard University in 1987 and completed postdoctoral fellowships at Yale University and Columbia Medical Center. He accepted a faculty position at Stanford in 1993 and was appointed director of the graduate program of biophysics in 1999. He served as department chair of both photon sciences, in 2013, and structural biology, in 2014; he was also a professor of cellular physiology and held an endowed chair during his 30-year career at the university.

An article in the Stanford Medicine news center called Weis a and he was noted for his expertise in X-ray crystallography; much of his work emphasized 3D structural composition of molecules in key regulatory pathways. His highlights his interest in intercellular junctions and Wnt signaling, which has been shown to promote tumor metastasis through mutation of regulatory genes throughout the pathway. Weis’ work looked specifically at signaling processes involving Wnt/β-catenin, which under normal conditions is employed for embryogenesis and tissue homeostasis. Dysregulation in the

Wnt/β-catenin pathway can lead to health problems such as cancer and Type 2 diabetes. Weis’ recent notable publications also included topics such as 3D structural analysis of G-protein coupled receptors such as the , which is necessary for Wnt signaling.

Weis was a five-time recipient of Stanford’s outstanding preclinical teaching award, served on multiple journal editorial boards and was elected to the U.S. National Academy of Sciences in 2019. Additionally, he was a member of the American Society for Cell Biology, the American Crystallographic Society and other scientific associations. His involvement in the scientific community expanded knowledge of structural biology, and his discoveries remain foundational to the progression of preclinical research.

He is survived by his wife, Sharin Halfon, and two older brothers, Philip and Richard Weis.  

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Lydia Smith

Lydia Smith has a B.S. in molecular cell biology and a minor in chemistry, which she received from California State University, Long Beach. She is continuing on to receive her Ph.D. in microbiology and immunology at the University of Utah and is a volunteer contributor for ASBMB Today. 

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.